Cite
Santoro A, Angelico G, Piermattei A, et al. Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease. Front Oncol. 2019;9:778doi: 10.3389/fonc.2019.00778.
Santoro, A., Angelico, G., Piermattei, A., Inzani, F., Valente, M., Arciuolo, D., Spadola, S., Mulè, A., Zorzato, P., Fagotti, A., Scambia, G., & Zannoni, G. F. (2019). Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease. Frontiers in oncology, 9778. https://doi.org/10.3389/fonc.2019.00778
Santoro, Angela, et al. "Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease." Frontiers in oncology vol. 9 (2019): 778. doi: https://doi.org/10.3389/fonc.2019.00778
Santoro A, Angelico G, Piermattei A, Inzani F, Valente M, Arciuolo D, Spadola S, Mulè A, Zorzato P, Fagotti A, Scambia G, Zannoni GF. Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease. Front Oncol. 2019 Aug 19;9:778. doi: 10.3389/fonc.2019.00778. eCollection 2019. PMID: 31482065; PMCID: PMC6709655.
Copy
Download .nbib